Hans-Kittil Viermyr
Overview
Explore the profile of Hans-Kittil Viermyr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Viermyr H, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas J, et al.
EBioMedicine
. 2024 Dec;
111():105511.
PMID: 39731852
Background: The Bari-SolidAct randomized controlled trial compared baricitinib with placebo in patients with severe COVID-19. A post hoc analysis revealed a higher incidence of serious adverse events (SAEs) among SARS-CoV-2-vaccinated...
2.
Viermyr H, Halvorsen B, Sagen E, Michelsen A, Barrat-Due A, Kasine T, et al.
J Intern Med
. 2024 Jul;
296(3):249-259.
PMID: 39011800
Objectives: To investigate temporal changes in the association between SARS-CoV2 viral load (VL) and markers of inflammation during hospitalization, as well as the ability of these markers alone or in...
3.
Halvorsen B, Viermyr H, Ueland T, Sagen E, Michelsen A, Bjerkeli V, et al.
J Infect
. 2024 May;
89(1):106176.
PMID: 38719108
No abstract available.
4.
De Bortoli A, Nordoy I, Connelly J, Viermyr H, Bjerkreim R, Broch K, et al.
Int J Cardiol
. 2024 Jan;
400:131809.
PMID: 38272129
Background: Evidence-based guidelines for cardiac sarcoidosis (CS) regarding use of second- and third-line agents, treatment duration, surveillance and prognostic factors are lacking. Objective: To analyze the clinical presentation, diagnostics, treatment,...